Marked potentiation of the plasminogenolytic activity of pro-urokinase by unfractionated heparin and a low molecular-weight heparin.
Dosne
A M
AM
Lab. Immunopharmacologie Exptle, CNRS UA-579, Paris, France.
Bendetowicz
A V
AV
Kher
A
A
Samama
M
M
D005343:Fibrinolytic Agents / Q000378:metabolism*; D006493:Heparin / Q000494:pharmacology*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D066298:In Vitro Techniques; D008175:Lung Neoplasms / Q000201:enzymology; D010960:Plasminogen Activators / Q000378:metabolism*; D013917:Thrombin / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D010960:Plasminogen Activators; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator